Advertisement
Advertisement
U.S. markets closed
Advertisement
Advertisement
Advertisement
Advertisement

MERCK Kommanditgesellschaft auf Aktien (MRK.DE)

XETRA - XETRA Delayed Price. Currency in EUR
Add to watchlist
172.40+4.70 (+2.80%)
At close: 05:39PM CEST
Advertisement
Full screen
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close167.70
Open169.25
Bid172.20 x 6700
Ask172.25 x 11200
Day's Range168.60 - 174.95
52 Week Range142.80 - 231.50
Volume598,209
Avg. Volume341,903
Market Cap74.956B
Beta (5Y Monthly)0.56
PE Ratio (TTM)23.53
EPS (TTM)7.33
Earnings DateAug 04, 2022
Forward Dividend & Yield1.85 (1.07%)
Ex-Dividend DateApr 25, 2022
1y Target Est219.00
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
N/A

Subscribe to Yahoo Finance Plus to view Fair Value for MRK.DE

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
    View more
    • Reuters

      Merck KGaA predicts strong earnings growth on lab demand

      FRANKFURT (Reuters) -Germany's Merck KGaA expects strong earnings growth this year as its laboratory gear division benefits from drugmakers' efforts to explore new biotechnologies, even as demand related to COVID-19 has probably reached its peak. "Life Science will remain the strongest growth engine for Merck," said the company, which also makes pharmaceuticals and speciality chemicals for semiconductor manufacturers. Fourth-quarter adjusted EBITDA rose 17.6% to 1.46 billion euros ($1.62 billion), slightly below an analyst consensus of 1.48 billion euros posted on Merck's website.

    • Reuters

      German chip chemical supplier Merck to invest 500 million euros in Taiwan

      German supplier of chemicals and materials used in making semiconductors, Merck KGaA, announced on Tuesday it is to invest 500 million euros in Taiwan over the next five to seven years, primarily in semiconductor technologies. Merck said it would be its largest investment in Taiwan since it established operations there in 1989. "We strengthen our local production and new capabilities to support fast-growing semiconductor demand in Taiwan but also to cater to an increasing demand in the rest of the world," Beckmann said, adding that the investment would expand Merck's footprint in the island's southern city of Kaohsiung. Merck's announcement follows that of Taiwan Semiconductor Manufacturing Co Ltd (TSMC) last month, when the world's largest contract chip maker said it will set up a new chip factory in Kaohsiung to boost production amid a global chip shortage.

    Advertisement
    Advertisement